| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |